John J. Miller addresses psychotropic medication executive order concerns

Dr. John J. Miller, the Editor-in-Chief of Psychiatric Times, has shared his concerns regarding a recent executive order affecting psychotropic medications. The executive order, issued on February 13, 2025, has raised alarm among psychiatrists, as it calls for an assessment of several medications essential for treatment. Miller stated that the order could spread misinformation and restrict access to important therapies. He emphasized that many psychiatric professionals are surprised and worried about this directive. He pointed out the solid scientific foundation supporting the use of these medications when prescribed correctly. On March 21, 2025, the American Psychiatric Association and other major groups issued a joint statement reaffirming the value of evidence-based medicine. Miller supported this view, stressing the importance of the relationship between patients and their clinicians. He explained that psychiatrists aim to provide safe, effective treatments tailored to each patient's needs. Miller addressed concerns around the responsible use of medications. He compared the situation in psychiatry to general medicine, noting that not every symptom indicates a specific condition. This analogy highlights the need for proper diagnosis and treatment in psychiatry as well. The stigma surrounding psychiatry is a long-standing issue, Miller added. He acknowledged that many people criticize the field because they do not fully understand it. He pointed out the brain's complexity and stated that, even as experts, psychiatrists are still learning. He encouraged his colleagues to remain dedicated to their work and maintain their knowledge. While there will always be critics, he believes that practicing evidence-based medicine is crucial for future advancements in the field.